News & Views
Global Drug Development Firm to create Edinburgh HQ
Sep 10 2010
Drug development company TPP Global Development is set to establish new headquarters in Edinburgh’s BioQuarter, creating up to 15 high value jobs initially, First Minister Alex Salmond recently announced. The Government is supporting the project with the offer of £200,000 in Regional Selective Assistance.
TPP licenses intellectual property (IP) from universities and research institutes. It has raised £9.6 million, including £2million from Scottish Enterprise’s Scottish Venture Fund, to develop this into preclinical drug assets. These will be sold to large pharmaceutical or biotech businesses or spun out into separate companies with the potential to create more jobs in Scotland. The company was said to have chosen Scotland as a base because of the existing highly ranked life science universities, strong local skill base and infrastructure able to support its business needs. It will move to temporary accommodation in the capital and locate at Scottish Enterprise’s new custom built facility at Edinburgh BioQuarter within two years.
First Minister Alex Salmond said: “The Scottish Government is doing all that it can to create jobs and investment and I am delighted that TPP has chosen to locate its headquarters in Scotland. The decision to locate in Edinburgh highlights the strength of Scotland’s life sciences sector and demonstrates Scotland has the quality infrastructure and workforce to deliver success. This ambitious new project will deliver £9.6 million of investment and bring high value jobs to the capital. Scotland has a proud reputation for pioneering innovation and research and this announcement will strengthen links between Scotland’s research and business community through commercialising this valuable knowledge.”
Lena Wilson, Chief Executive of Scottish Enterprise, said: “TPP’s investment in Edinburgh is excellent news for the Scottish economy generally and will further enhance our growing international reputation in attracting successful and ambitious life sciences organisations.
“We are creating the kind of supportive business environment that will hopefully see many more companies follow TPP’s example in locating HQ functions here in Scotland. Through projects like the Edinburgh BioQuarter, we are building on our clear strengths in life sciences such as our academic base, the quality of our research and our skilled motivated people, all of which TPP and many more global life sciences companies clearly value.”
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark